LD 1177 LR 1211(01)
An Act To Increase Access to Intranasal Naloxone Hydrochloride for Syringe Services Programs
Preliminary Fiscal Impact Statement for Original Bill
Sponsor: Rep. McDonald of Stonington
Committee: Health and Human Services
Fiscal Note Required: No
Preliminary Fiscal Impact Statement
Minor cost increase - General Fund
Fiscal Detail and Notes
Any additional costs to the Department of Health and Human Services to adopt the changes in this bill are expected to be minor and can be absorbed within existing budgeted resources.